Single Dose Radiotherapy Services Market Report 2024

The single-dose radiotherapy services market size has grown strongly in recent years. It will grow from $1.37 billion in 2023 to $1.48 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. During the historic period, growth was driven by technological advancements, the integration of big data analytics, the development of portable radiotherapy devices, increased utilization of robotics in radiotherapy procedures, and the adoption of cloud-based treatment planning systems.

The single-dose radiotherapy services market size is expected to see strong growth in the next few years. It will grow to $2.02 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The forecasted growth can be attributed to the increasing adoption of single-dose therapies, rising demand for non-invasive treatments, expanding healthcare expenditure, growth in the geriatric population, and the expansion of telemedicine services. Major trends expected in the forecast period include advancements in technology, integration of big data analytics, development of portable radiotherapy devices, increased utilization of robotics in radiotherapy procedures, and the adoption of cloud-based treatment planning systems.

The market for single-dose radiotherapy services is expected to grow due to the increasing prevalence of cancer. Cancer encompasses diseases characterized by abnormal cell growth, often leading to tumors that spread and disrupt normal bodily functions. Factors contributing to higher cancer rates include aging populations, lifestyle changes, environmental factors, and improved detection methods. Single-dose radiotherapy services play a crucial role in addressing this trend by providing rapid and effective treatment that targets cancer cells, potentially improving patient outcomes and reducing the overall burden of the disease. For instance, according to the International Agency for Research on Cancer (IARC), global new cases of breast cancer rose from 2.26 million in 2020 to 2.31 million in 2022, underscoring the increasing demand for effective cancer treatments.

Leading companies in the single-dose radiotherapy services market are focusing on innovation, such as developing radiation therapy computed tomography (CT) solutions. These advanced imaging systems enhance treatment precision and simplify simulation processes in oncology care. For example, GE HealthCare recently introduced Revolution RT and an updated Intelligent Radiation Therapy (IRT) Platform in May 2024. Revolution RT improves radiotherapy simulation accuracy, while the updated iRT platform integrates artificial intelligence to optimize treatment plans and streamline workflows. These technological advancements in radiotherapy not only enhance imaging accuracy and treatment precision but also personalize therapy plans based on patient needs, thereby improving the efficiency and accessibility of single-dose radiotherapy services.

In April 2021, Siemens Healthineers AG acquired Varian Medical Systems Inc., a move aimed at expanding its oncology portfolio and strengthening its global healthcare market position. Varian Medical Systems Inc., based in the US, specializes in precise single-dose and hypofractionated radiation treatments, complementing Siemens Healthineers' capabilities in cancer treatment solutions.

Major companies operating in the single dose radiotherapy services market are Hitachi Ltd., Varian Medical Systems Inc., Boston Scientific Corporation, Elekta AB, GenesisCare, Accuray Incorporated, IBA Dosimetry GmbH, Sirtex Medical Limited, Telix Pharmaceuticals Limited, ViewRay Inc., RaySearch Laboratories AB, RefleXion Medical Inc., Sensus Healthcare Inc., C-RAD AB, Panacea Medical Technologies Pvt. Ltd., Advanced Oncotherapy Plc, ProTom International Inc., Isoray Inc., IntraOp Medical Corporation, Alliance Oncology, Nanobiotix, Xcision Medical Systems LLC, Oraya Therapeutics Inc.

North America was the largest region in the single dose radiotherapy services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single dose radiotherapy services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the single dose radiotherapy services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Single-dose radiotherapy services involve administering a single, high dose of radiation to a tumor during one treatment session, offering benefits such as reduced hospital visits, quick symptom relief, and improved quality of life in palliative care.

The primary types of single-dose radiotherapy services include internal beam radiotherapy and external beam radiotherapy. Internal beam radiotherapy, also known as brachytherapy, places a radioactive source directly inside or near the tumor to deliver high radiation doses to the cancerous area while minimizing exposure to healthy tissues. This approach finds applications in treating cancers such as prostate and breast cancer and is offered by specialized cancer institutes and radiotherapy centers.

The single-dose radiotherapy services market research report is one of a series of new reports that provides single-dose radiotherapy services market statistics, including single-dose radiotherapy services industry global market size, regional shares, competitors with a single-dose radiotherapy services market share, detailed single-dose radiotherapy services market segments, market trends, and opportunities, and any further data you may need to thrive in the single-dose radiotherapy services industry. This single-dose radiotherapy services research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The single-dose radiotherapy services market includes revenues earned by entities by providing services such as palliative care services, radiation delivery, radiotherapy treatment planning, regular monitoring, and patient consultation and related linear accelerators, imaging systems, immobilization devices, beam shaping devices, and radiation safety equipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.